Winter Update 2016
The staff at the Southeastern Center for Fertility and Reproductive Surgery hopes each and every one of you have/had a very Merry Christmas and a prosperous and blessed New Year! We hope that if you've been struggling with infertility that you will make an appointment to see us soon. In the majority of cases, we can help. Perhaps you would like a second opinion? Call today to schedule an appointment. (865)777-0088. Don't forget that we also provide regular gynecological services such as annual exams and hormonal management. And we can almost always get you an appointment within 2 weeks, and sometimes sooner by way of our cancellation list!
If you haven't already noticed, our nurse practitioner Autumn Galbraith is expecting a little one of her own. Her due date is February 8th. We anticipate her to take maternity leave starting in early February through early May 2017. We will have another nurse practitioner to cover for her while she is gone so that you can keep your appointments for general GYN care. Please join us in congratulating her the next time you're in the office!
Insurance and Demographic Changes
Please remember that insurance changes take effect after the first of the year. If your insurance is changing or you have new contact information, please make sure that information is up to date prior to any appointments you have with our office after the first of the year. This will ensure a smooth transition for both you and us into 2017!
- January is Birth Defects Prevention Month
- January is Cervical Health Awareness Month
- January is Thyroid Awareness Month
- February is American Heart Month
- March is National Endometriosis Awareness Month
Are Poor Swimmers Genetic?
Intracytoplasmic sperm injection (ICSI) is a procedure performed during in vitro fertilization (IVF) where a single sperm is injected directly into the egg for fertilization as opposed to traditional IVF where several sperm are placed near an egg for fertilization. ICSI is typically performed for reasons such as a low sperm count, abnormally shaped sperm, slow/sluggish sperm, previous IVF cycles where there was a low/no fertilization rate, the need for sperm collection from the testicles due to, for example, a history of a vasectomy, or poor quality of frozen sperm.
A recent study published in Human Reproduction evaluated the semen quality of young adult ICSI offspring. They studied 54 young adult men who were conceived via IVF with ICSI in the early 1990's, and found that average sperm concentration, total sperm count, and total motile sperm count were significantly lower than in men who were conceived spontaneously. The thought is that since these men were conceived by ICSI because of severe male-factor infertility, that these male offspring have inherited poor sperm quality from their fathers.
The Burden of Endometriosis
Endometriosis is a chronic inflammatory disease in which endometrial (uterine lining)-like tissue grows outside the uterus. Symptoms of endometriosis include pelvic pain, menstrual cramps, painful intercourse, and abnormal/irregular uterine bleeding. It is also associated with infertility.
An online study of women aged 18-49 years was conducted, and survey data were used to estimate the prevalence and symptomatic burden of diagnosed endometriosis in women in the United States. The prevalence of diagnosed endometriosis was estimated at 6.1% (2,922 of 48,020 women surveyed. 52.7% of women were 18-29 years of age when they were diagnosed with endometriosis. Most (86.2%) women experienced symptoms before diagnosis. More women with (versus without) diagnosed endometriosis had menstrual pelvic pain/cramping (52.7 versus 45.2%), non-menstrual pelvic pain/cramping (36.7 versus 14.3%), infertility (11.6 versus 3.4%), and dyspareunia (pain with intercourse) (29.5 versus 13.4%). Women with endometriosis were also more likely to report severe symptoms for menstrual pelvic pain/cramping, for non-menstrual pelvic pain/cramping, and dyspareunia. In conclusion, the prevalence of diagnosed endometriosis among women is notable, and affected women experience a substantial symptom burden. The societal cost for this in the U.S. is over $50 billion dollars.
But, many new treatments are available! Please see us if you are needlessly suffering from this difficult disease!